Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C25H31(125)IN6O2S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1569294-14-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1569294-14-9 Structure
  • Basic information

    1. Product Name: C25H31(125)IN6O2S
    2. Synonyms:
    3. CAS NO:1569294-14-9
    4. Molecular Formula:
    5. Molecular Weight: 604.626
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1569294-14-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C25H31(125)IN6O2S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C25H31(125)IN6O2S(1569294-14-9)
    11. EPA Substance Registry System: C25H31(125)IN6O2S(1569294-14-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1569294-14-9(Hazardous Substances Data)

1569294-14-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1569294-14-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,6,9,2,9 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1569294-14:
(9*1)+(8*5)+(7*6)+(6*9)+(5*2)+(4*9)+(3*4)+(2*1)+(1*4)=209
209 % 10 = 9
So 1569294-14-9 is a valid CAS Registry Number.

1569294-14-9Downstream Products

1569294-14-9Relevant articles and documents

Synthesis and biological evaluation of new quinoxaline derivatives of ICF01012 as melanoma-targeting probes

El Aissi, Radhia,Liu, Jianrong,Besse, Sophie,Canitrot, Damien,Chavignon, Olivier,Chezal, Jean-Michel,Miot-Noirault, Elisabeth,Moreau, Emmanuel

, p. 468 - 473 (2014)

The aim of this study was the synthesis and pharmacokinetic selection of a best melanin-targeting ligand for addressing anticancer agents to pigmented melanoma. Seven quinoxaline carboxamide derivatives were synthesized and radiolabeled with iodine-125. Biodistribution studies of compounds [ 125I]1a-g performed in melanoma-bearing mice tumor showed significant tumor uptake (range 2.43-5.68%ID/g) within 1 h after i.v. injection. Fast clearance of the radioactivity from the nontarget organs mainly via the urinary system gave high tumor-to-blood and tumor-to-muscle ratios. Given its favorable clearance and high tumor-melanoma uptake at 72 h, amide 1d was the most promising melanoma-targeting ligand in this series. Compound 1d will be used as building block for the design of new melanoma-selective drug delivery systems.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1569294-14-9